Public Health System Funding for isCGM Reduces Socioeconomic Disparities in Type 2 Diabetes Control: A Cohort Study - PubMed
a day ago
- #Healthcare Disparities
- #Continuous Glucose Monitoring
- #Type 2 Diabetes
- Public funding for isCGM (intermittently scanned continuous glucose monitoring) systems reduces socioeconomic disparities in glycemic control for Type 2 diabetes (T2D) patients.
- The study involved 402 T2D patients from three hospitals, with isCGM provided free of charge through public healthcare funding.
- Before isCGM use, HbA1c levels were higher in the lowest socioeconomic status (SES) quartile (8.9%) compared to the highest (8.2%).
- After isCGM implementation, HbA1c levels decreased significantly across all SES groups, with the lowest quartile showing a 1.0% reduction and the highest a 0.6% reduction.
- Post-intervention, differences in HbA1c levels between SES quartiles were no longer statistically significant, indicating reduced disparities.
- The study concludes that public funding for isCGM improves glycemic control and reduces socioeconomic healthcare disparities in T2D patients on insulin therapy.